GE HealthCare Technologies Inc. — Cyborg Score 7/10

Strong
Medical Devices & Diagnostics / Healthcare Technology

Strategic Profile

GE HealthCare guides for 3-4% organic revenue growth in 2026 with adjusted EPS of $4.95-$5.15. Growth is expected from the Imaging and Pharmaceutical Diagnostics segments, ongoing innovation in cloud-first imaging, and integration of acquisitions like Intelerad. The company maintains a strong competitive position through AI-enabled products and a record backlog of orders.

Cyborg Score Rationale

GE HealthCare has underperformed the broader market but analysts are cautiously optimistic, with consensus being a 'Moderate Buy' and the stock potentially undervalued by 41%. The company is advancing AI-enabled imaging products and clinical collaborations with strong product innovation momentum.

Top Insights

  • Q4 2025 earnings beat expectations with adjusted EPS of $1.44 vs. $1.43 consensus and revenue of $5.7B vs. $5.6B forecast.
  • Company enters 2026 with strong momentum, record backlog, continued enterprise deal activity, and Heartbeat operating system deployment driving growth and margin expansion.
  • AI-enabled imaging products and clinical collaborations including work with U.S. Anesthesia Partners and newly cleared Allia Moveo system represent near-term growth catalysts.
  • 2025 free cash flow was impacted by $285M in tariffs, but current valuation remains attractive even without tariff reduction relief.

Named Competitors

  • Siemens Healthineers — Comprehensive medical diagnostics and imaging solutions
  • Philips Healthcare — Integrated connected care technology and diagnostics
  • Canon Medical Systems — Medical imaging equipment and diagnostics

Recent Developments

  • (February 2026) Declared $0.035 per share cash dividend for Q1 2026
  • (February 2026) Q4 2025 earnings beat with $5.7B revenue and guidance above analyst expectations
  • (February 2026) Named to Fortune World's Most Admired Companies 2026 list

Open the full interactive GE HealthCare Technologies Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →